Loading…
Effects of salbutamol upon performance on an operant screen for antidepressants
The beta adrenergic (beta) agonist salbutamol increased reinforcement rates and decreased response rates on a differential-reinforcement-of-low-rate (DRL) 72-S schedule. These changes in DRL 72-S schedule performance are also produced by most clinically used antidepressants. The effects of salbutamo...
Saved in:
Published in: | Psychopharmacologia 1993-11, Vol.113 (1), p.1-10 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c342t-29c661e10b6ba1f92db1c7314cf908306773e73cef600542c558ee90bc36fe0b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c342t-29c661e10b6ba1f92db1c7314cf908306773e73cef600542c558ee90bc36fe0b3 |
container_end_page | 10 |
container_issue | 1 |
container_start_page | 1 |
container_title | Psychopharmacologia |
container_volume | 113 |
creator | DUNN, R. T RICHARDS, J. B SEIDEN, L. S |
description | The beta adrenergic (beta) agonist salbutamol increased reinforcement rates and decreased response rates on a differential-reinforcement-of-low-rate (DRL) 72-S schedule. These changes in DRL 72-S schedule performance are also produced by most clinically used antidepressants. The effects of salbutamol on a DRL 72-S schedule were dose-dependently antagonized by the beta antagonist metoprolol, but not changed by the 5HT antagonist methysergide. Additionally, neither salbutamol nor the antagonism of salbutamol by metoprolol caused disruption of DRL 72-S schedule performance. These results indicate that stimulation of beta receptors, and not of 5HT receptors, mediates salbutamol antidepressant-like effects on a DRL 72-S schedule. |
doi_str_mv | 10.1007/BF02244325 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76311213</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16592621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c342t-29c661e10b6ba1f92db1c7314cf908306773e73cef600542c558ee90bc36fe0b3</originalsourceid><addsrcrecordid>eNqFkDFPwzAQhS0EKqWwsCNlQAxIAZ8vsZMRqhaQKnWBOXLcsxSUxMFOBv49Rq3KyC3v7r1PNzzGroE_AOfq8XnNhcgyFPkJm0PUVHAlTtmcc8QUIS_O2UUInzxOVmQzNlOFFAXgnG1X1pIZQ-JsEnRbT6PuXJtMg-uTgbx1vtO9oSSeuk9ctHQ_JsF4oj6JaXTHZkeDpxDiGi7ZmdVtoKuDLtjHevW-fE0325e35dMmNZiJMRWlkRIIeC1rDbYUuxqMQsiMLXmBXCqFpNCQlZznmTB5XhCVvDYoLfEaF-xu_3fw7muiMFZdEwy1re7JTaFSEgEE4L8gyLwUMpILdr8HjXcheLLV4JtO--8KePVbc_VXc4RvDl-nuqPdET30GvPbQ66D0a2NrZkmHDFURZmDwh-iA4N7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16592621</pqid></control><display><type>article</type><title>Effects of salbutamol upon performance on an operant screen for antidepressants</title><source>Springer LINK Archives</source><creator>DUNN, R. T ; RICHARDS, J. B ; SEIDEN, L. S</creator><creatorcontrib>DUNN, R. T ; RICHARDS, J. B ; SEIDEN, L. S</creatorcontrib><description>The beta adrenergic (beta) agonist salbutamol increased reinforcement rates and decreased response rates on a differential-reinforcement-of-low-rate (DRL) 72-S schedule. These changes in DRL 72-S schedule performance are also produced by most clinically used antidepressants. The effects of salbutamol on a DRL 72-S schedule were dose-dependently antagonized by the beta antagonist metoprolol, but not changed by the 5HT antagonist methysergide. Additionally, neither salbutamol nor the antagonism of salbutamol by metoprolol caused disruption of DRL 72-S schedule performance. These results indicate that stimulation of beta receptors, and not of 5HT receptors, mediates salbutamol antidepressant-like effects on a DRL 72-S schedule.</description><identifier>ISSN: 0033-3158</identifier><identifier>EISSN: 1432-2072</identifier><identifier>DOI: 10.1007/BF02244325</identifier><identifier>PMID: 7862813</identifier><identifier>CODEN: PSYPAG</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Albuterol - antagonists & inhibitors ; Albuterol - pharmacology ; Animals ; Antidepressive Agents - pharmacology ; Biological and medical sciences ; Conditioning, Operant - drug effects ; Drug Evaluation, Preclinical ; Male ; Medical sciences ; Methysergide - pharmacology ; Metoprolol - pharmacology ; Neuropharmacology ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Rats ; Rats, Sprague-Dawley ; Reinforcement Schedule</subject><ispartof>Psychopharmacologia, 1993-11, Vol.113 (1), p.1-10</ispartof><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c342t-29c661e10b6ba1f92db1c7314cf908306773e73cef600542c558ee90bc36fe0b3</citedby><cites>FETCH-LOGICAL-c342t-29c661e10b6ba1f92db1c7314cf908306773e73cef600542c558ee90bc36fe0b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3789517$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7862813$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DUNN, R. T</creatorcontrib><creatorcontrib>RICHARDS, J. B</creatorcontrib><creatorcontrib>SEIDEN, L. S</creatorcontrib><title>Effects of salbutamol upon performance on an operant screen for antidepressants</title><title>Psychopharmacologia</title><addtitle>Psychopharmacology (Berl)</addtitle><description>The beta adrenergic (beta) agonist salbutamol increased reinforcement rates and decreased response rates on a differential-reinforcement-of-low-rate (DRL) 72-S schedule. These changes in DRL 72-S schedule performance are also produced by most clinically used antidepressants. The effects of salbutamol on a DRL 72-S schedule were dose-dependently antagonized by the beta antagonist metoprolol, but not changed by the 5HT antagonist methysergide. Additionally, neither salbutamol nor the antagonism of salbutamol by metoprolol caused disruption of DRL 72-S schedule performance. These results indicate that stimulation of beta receptors, and not of 5HT receptors, mediates salbutamol antidepressant-like effects on a DRL 72-S schedule.</description><subject>Albuterol - antagonists & inhibitors</subject><subject>Albuterol - pharmacology</subject><subject>Animals</subject><subject>Antidepressive Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Conditioning, Operant - drug effects</subject><subject>Drug Evaluation, Preclinical</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methysergide - pharmacology</subject><subject>Metoprolol - pharmacology</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Reinforcement Schedule</subject><issn>0033-3158</issn><issn>1432-2072</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><recordid>eNqFkDFPwzAQhS0EKqWwsCNlQAxIAZ8vsZMRqhaQKnWBOXLcsxSUxMFOBv49Rq3KyC3v7r1PNzzGroE_AOfq8XnNhcgyFPkJm0PUVHAlTtmcc8QUIS_O2UUInzxOVmQzNlOFFAXgnG1X1pIZQ-JsEnRbT6PuXJtMg-uTgbx1vtO9oSSeuk9ctHQ_JsF4oj6JaXTHZkeDpxDiGi7ZmdVtoKuDLtjHevW-fE0325e35dMmNZiJMRWlkRIIeC1rDbYUuxqMQsiMLXmBXCqFpNCQlZznmTB5XhCVvDYoLfEaF-xu_3fw7muiMFZdEwy1re7JTaFSEgEE4L8gyLwUMpILdr8HjXcheLLV4JtO--8KePVbc_VXc4RvDl-nuqPdET30GvPbQ66D0a2NrZkmHDFURZmDwh-iA4N7</recordid><startdate>19931101</startdate><enddate>19931101</enddate><creator>DUNN, R. T</creator><creator>RICHARDS, J. B</creator><creator>SEIDEN, L. S</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19931101</creationdate><title>Effects of salbutamol upon performance on an operant screen for antidepressants</title><author>DUNN, R. T ; RICHARDS, J. B ; SEIDEN, L. S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c342t-29c661e10b6ba1f92db1c7314cf908306773e73cef600542c558ee90bc36fe0b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Albuterol - antagonists & inhibitors</topic><topic>Albuterol - pharmacology</topic><topic>Animals</topic><topic>Antidepressive Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Conditioning, Operant - drug effects</topic><topic>Drug Evaluation, Preclinical</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methysergide - pharmacology</topic><topic>Metoprolol - pharmacology</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Reinforcement Schedule</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DUNN, R. T</creatorcontrib><creatorcontrib>RICHARDS, J. B</creatorcontrib><creatorcontrib>SEIDEN, L. S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Psychopharmacologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DUNN, R. T</au><au>RICHARDS, J. B</au><au>SEIDEN, L. S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of salbutamol upon performance on an operant screen for antidepressants</atitle><jtitle>Psychopharmacologia</jtitle><addtitle>Psychopharmacology (Berl)</addtitle><date>1993-11-01</date><risdate>1993</risdate><volume>113</volume><issue>1</issue><spage>1</spage><epage>10</epage><pages>1-10</pages><issn>0033-3158</issn><eissn>1432-2072</eissn><coden>PSYPAG</coden><abstract>The beta adrenergic (beta) agonist salbutamol increased reinforcement rates and decreased response rates on a differential-reinforcement-of-low-rate (DRL) 72-S schedule. These changes in DRL 72-S schedule performance are also produced by most clinically used antidepressants. The effects of salbutamol on a DRL 72-S schedule were dose-dependently antagonized by the beta antagonist metoprolol, but not changed by the 5HT antagonist methysergide. Additionally, neither salbutamol nor the antagonism of salbutamol by metoprolol caused disruption of DRL 72-S schedule performance. These results indicate that stimulation of beta receptors, and not of 5HT receptors, mediates salbutamol antidepressant-like effects on a DRL 72-S schedule.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>7862813</pmid><doi>10.1007/BF02244325</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0033-3158 |
ispartof | Psychopharmacologia, 1993-11, Vol.113 (1), p.1-10 |
issn | 0033-3158 1432-2072 |
language | eng |
recordid | cdi_proquest_miscellaneous_76311213 |
source | Springer LINK Archives |
subjects | Albuterol - antagonists & inhibitors Albuterol - pharmacology Animals Antidepressive Agents - pharmacology Biological and medical sciences Conditioning, Operant - drug effects Drug Evaluation, Preclinical Male Medical sciences Methysergide - pharmacology Metoprolol - pharmacology Neuropharmacology Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Rats Rats, Sprague-Dawley Reinforcement Schedule |
title | Effects of salbutamol upon performance on an operant screen for antidepressants |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A43%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20salbutamol%20upon%20performance%20on%20an%20operant%20screen%20for%20antidepressants&rft.jtitle=Psychopharmacologia&rft.au=DUNN,%20R.%20T&rft.date=1993-11-01&rft.volume=113&rft.issue=1&rft.spage=1&rft.epage=10&rft.pages=1-10&rft.issn=0033-3158&rft.eissn=1432-2072&rft.coden=PSYPAG&rft_id=info:doi/10.1007/BF02244325&rft_dat=%3Cproquest_cross%3E16592621%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c342t-29c661e10b6ba1f92db1c7314cf908306773e73cef600542c558ee90bc36fe0b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16592621&rft_id=info:pmid/7862813&rfr_iscdi=true |